64a262eeab212703ceaa9c9ab1a842e3 *DESCRIPTION
a0186f70cc54d9df0fc4d8931949c27c *LICENSE
5fd751c2405cc37cae925fd8fa21636f *NAMESPACE
f6fc1fe26a27f10e0d946f97ecb0ac8c *R/prolif_d.R
5fe2c230329a4e7e4b59dc591f262f4e *R/prolif_fd.R
95889959aee9a783f80fbc70b860f0ca *R/prolif_fq.R
6fc3647cbc4122cddaf88f633f4b5f4f *R/prolif_q.R
288e72e9e6294ed81d708e832f3761c4 *R/prolif_tot.R
0fdce6fcc2070116328109817434f250 *R/q.mle.emg.estimate.R
49fc03b7ce71106d88a640fd8bc4acf4 *R/q.mle.norm.estimate.R
260f7478aa503589cddb863569e25bdf *R/q.rates.R
e5ed3ba6c99610fa0bc5a9f4178a4bcb *R/qsurvival.nllik.R
9142af05d3a6f6f50c7f08ff0dc52081 *R/split.R
7c25ce97bf2caa1462755b74ca008e85 *data/ca1d.erlotinib.rda
9c32e6febd87fa9e6b1349d12e59b4bd *data/ca1d.erlotinib.totals.rda
ebf6cac4585808e7a001566730642a2e *man/ca1d.erlotinib.Rd
f17d74078f0bde86cc95689c5a6693cb *man/ca1d.erlotinib.totals.Rd
047f08a3033d9a1d85101dd37e250e1c *man/fracprolif-package.Rd
a89959d59e68d27a95a5b6246ce36c12 *man/prolif_d.Rd
d6680d832966b86382c0fd525025ce0f *man/prolif_fd.Rd
c8a1861e68c1c11b5815e047d768810b *man/prolif_fq.Rd
d6fd01bbb5d7c16d5c9a7a33c51011b5 *man/prolif_q.Rd
e15c9942934cc9c7b1c45c15a9aa8e73 *man/prolif_tot.Rd
5dbcc38c0069497dcf04c0245c5a138e *man/q.mle.emg.estimate.Rd
a36d23792b9e9db3ecc37a2efb4c62ee *man/q.mle.norm.estimate.Rd
bace5573626a09e6c9b68397d1fefa6c *man/q.rates.Rd
5c898448d56009b579ea9335feddbaf9 *man/qsurvival.nllik.Rd
282a6b5a9bb2971b9dc23a0e8f13d7d6 *man/split.Rd
